Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 310 entries
View as:

Study of Bile Acids in Patients With Peroxisomal Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00004442 Org: User:
Start: - End: 04/30/99 Due: 04/30/00

Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients

Phase: N/A Priority: Normal
NCT ID: NCT02147132 Org: User:
Start: 03/31/16 End: 08/25/17 Due: 08/25/18

Randomized Trial for Mixed Acute Rejection

Phase: N/A Priority: Normal
NCT ID: NCT00771875 Org: User:
Start: 09/30/08 End: 03/31/13 Due: 03/31/14

Letrozole for Lymphangioleiomyomatosis

Phase: N/A Priority: Normal
NCT ID: NCT01353209 Org: User:
Start: 05/31/11 End: 09/30/14 Due: 09/30/15

Belatacept With Early Steroid Withdrawal rATG and Everolimus in Renal Transplantation (BETTER Trial)

Phase: N/A Priority: Normal
NCT ID: NCT04849533 Org: User:
Start: 04/09/21 End: 07/31/24 Due: 07/31/25

AWAITS: A Web-based E-health Application for Active Illicit Opioid Users

Phase: N/A Priority: Normal
NCT ID: NCT03402672 Org: User:
Start: 11/08/17 End: 06/21/18 Due: 06/21/19

N-acetylcysteine in the Treatment of Depressive Symptoms in Bipolar Offspring

Phase: N/A Priority: Normal
NCT ID: NCT02865629 Org: User:
Start: 08/31/16 End: 09/30/19 Due: 09/30/20

Hypertonic Saline vs. Mannitol for Elevated Intercranial Pressure

Phase: N/A Priority: Normal
NCT ID: NCT01111682 Org: User:
Start: 04/30/10 End: 11/30/10 Due: 11/30/11

Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01330693 Org: User:
Start: 09/30/09 End: 11/30/15 Due: 11/30/16

Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing

Phase: N/A Priority: Normal
NCT ID: NCT05560477 Org: User:
Start: 04/26/23 End: 06/30/27 Due: 06/30/28

Feasibility of PET/CT to Detect the Oral/Pulmonary Distribution of Nicotine Following E-cigarette Use

Phase: N/A Priority: Normal
NCT ID: NCT03491059 Org: User:
Start: 02/16/18 End: 02/16/25 Due: 02/16/26

Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease

Phase: N/A Priority: Normal
NCT ID: NCT05115331 Org: User:
Start: 11/24/21 End: 11/24/25 Due: 11/24/26

Studying the Effects of Brain Stimulation on Cognitive Control and Associated EEG in Human Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT05251454 Org: User:
Start: 06/20/22 End: 02/28/26 Due: 02/28/27

Budesonide for Liver Transplant Immune Suppression

Phase: N/A Priority: Normal
NCT ID: NCT03304626 Org: User:
Start: 06/27/17 End: 12/31/19 Due: 12/31/20

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00682695 Org: User:
Start: 09/30/97 End: 10/31/24 Due: 10/31/25

REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation

Phase: N/A Priority: Normal
NCT ID: NCT05902533 Org: User:
Start: 08/14/23 End: 08/14/29 Due: 08/14/30

Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma

Phase: N/A Priority: Normal
NCT ID: NCT03278249 Org: User:
Start: 10/12/17 End: 01/01/22 Due: 01/01/23

Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine

Phase: N/A Priority: Normal
NCT ID: NCT00394095 Org: User:
Start: 12/31/06 End: 09/30/09 Due: 09/30/10

Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study

Phase: N/A Priority: Normal
NCT ID: NCT00885495 Org: User:
Start: 01/31/09 End: 08/31/10 Due: 08/31/11

Feasibility Assessment of Next-generation PET Technology and Procedures

Phase: N/A Priority: Normal
NCT ID: NCT03387618 Org: User:
Start: 09/19/17 End: 12/31/24 Due: 12/31/25

Smoking-Cessation and Stimulant Treatment (S-CAST)

Phase: N/A Priority: Normal
NCT ID: NCT01077024 Org: User:
Start: 02/28/10 End: 08/31/12 Due: 08/31/13

Use of Armodafinil for Fatigue in Sarcoidosis

Phase: N/A Priority: Normal
NCT ID: NCT00555347 Org: User:
Start: 10/31/07 End: 08/31/11 Due: 08/31/12

Standardized Criteria to Judge Diagnostic Urethrocystoscopy Skills

Phase: N/A Priority: Normal
NCT ID: NCT00631761 Org: User:
Start: 05/31/08 End: 06/30/08 Due: 06/30/09

A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00363116 Org: User:
Start: 04/30/99 End: 12/31/04 Due: 12/31/05

Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)

Phase: N/A Priority: Normal
NCT ID: NCT01202864 Org: User:
Start: 08/01/10 End: 08/01/17 Due: 08/01/18